These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 9612621
1. [Strategy for multimodal therapy of soft tissue sarcomas of the trunk and extremities]. Kettelhack C, Tunn U, Schlag PM. Chirurg; 1998 Apr; 69(4):393-401. PubMed ID: 9612621 [Abstract] [Full Text] [Related]
2. [Results of isolated hyperthermic extremity perfusion in soft tissue sarcomas within the scope of a multimodality treatment concept]. Schwarzbach M, Lehnert T, Willeke F, Hinz U, Herfarth C. Chirurg; 1996 Dec; 67(12):1237-43. PubMed ID: 9081786 [Abstract] [Full Text] [Related]
3. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases]. Moureau-Zabotto L, Thomas L, Bui BN, Chevreau C, Stockle E, Martel P, Bonneviale P, Marques B, Coindre JM, Kantor G, Matsuda T, Delannes M. Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593 [Abstract] [Full Text] [Related]
4. Optimizing local control in soft tissue sarcoma of the extremity. Gwin JL, Bell JL. Oncology (Williston Park); 1994 Jul; 8(7):25-31; discussion 32, 37-8, 41. PubMed ID: 7917837 [Abstract] [Full Text] [Related]
5. [Systemic therapy and hyperthermia for locally advanced soft tissue sarcoma]. Lindner LH, Angele M, Dürr HR, Rauch J, Bruns C. Chirurg; 2014 May; 85(5):398-403. PubMed ID: 24740176 [Abstract] [Full Text] [Related]
11. A staging system for soft-tissue sarcoma and its evaluation in relation to treatment. Tomita Y, Kuratsu S, Naka N, Uchida A, Ono K, Ohsawa M, Aozasa K. Int J Cancer; 1994 Jul 15; 58(2):168-73. PubMed ID: 8026876 [Abstract] [Full Text] [Related]
12. Hyperthermic isolated limb perfusion with tumour necrosis factor-alpha and melphalan as palliative limb-saving treatment in patients with locally advanced soft-tissue sarcomas of the extremities with regional or distant metastases. Is it worthwhile? Olieman AF, van Ginkel RJ, Molenaar WM, Schraffordt Koops H, Hoekstra HJ. Arch Orthop Trauma Surg; 1998 Jul 15; 118(1-2):70-4. PubMed ID: 9833110 [Abstract] [Full Text] [Related]
13. [Soft tissue sarcoma: prognostic factors and multimodal treatment]. Hoos A, Lewis JJ, Brennan MF. Chirurg; 2000 Jul 15; 71(7):787-94. PubMed ID: 10986600 [Abstract] [Full Text] [Related]
14. Hyperthermic isolated limb perfusion, preoperative radiotherapy, and surgery (PRS) a new limb saving treatment strategy for locally advanced sarcomas. Stevenson MG, Seinen JM, Pras E, Brouwers AH, van Ginkel RJ, van Leeuwen BL, Suurmeijer AJH, Been LB, Hoekstra HJ. J Surg Oncol; 2018 Jun 15; 117(7):1447-1454. PubMed ID: 29484661 [Abstract] [Full Text] [Related]
15. Limb-sparing therapy for soft tissue sarcomas. Pollock RE. Curr Opin Gen Surg; 1994 Jun 15; ():224-9. PubMed ID: 7583975 [Abstract] [Full Text] [Related]
16. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities. Noorda EM, Vrouenraets BC, Nieweg OE, van Coevorden F, van Slooten GW, Kroon BB. Cancer; 2003 Oct 01; 98(7):1483-90. PubMed ID: 14508836 [Abstract] [Full Text] [Related]
17. [Interdisciplinary treatment of soft tissue sarcoma of the extremities]. Jakob J, Henzler T, Kasper B, Marx A, Hohenberger P. Chirurg; 2014 May 01; 85(5):383-90. PubMed ID: 24763695 [Abstract] [Full Text] [Related]
18. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities. Lejeune FJ, Pujol N, Liénard D, Mosimann F, Raffoul W, Genton A, Guillou L, Landry M, Chassot PG, Chiolero R, Bischof-Delaloye A, Leyvraz S, Mirimanoff RO, Bejkos D, Leyvraz PF. Eur J Surg Oncol; 2000 Nov 01; 26(7):669-78. PubMed ID: 11078614 [Abstract] [Full Text] [Related]
19. [Intraoperative radiotherapy in advanced soft tissue sarcoma of the extremities]. Schwarzbach M, Willeke F, Eble M, Lehnert T, Ewerbeck V, Wannenmacher M, Herfarth C. Langenbecks Arch Chir Suppl Kongressbd; 1996 Nov 01; 113():214-7. PubMed ID: 9101835 [Abstract] [Full Text] [Related]
20. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma. Vaynrub M, Taheri N, Ahlmann ER, Yao C, Fedenko AN, Allison DC, Chawla SP, Menendez LR. J Surg Oncol; 2015 Feb 01; 111(2):152-7. PubMed ID: 25175933 [Abstract] [Full Text] [Related] Page: [Next] [New Search]